(R)-tert-Butyl (1-(benzylthio)-3-hydroxypropan-2-yl)carbamate

Catalog No. :
ACBNJI481
CAS No. :
139428-96-9
Molecular Formula :
C15H23NO3S
Molecular Weight :
297.42

IUPAC Name:tert-butyl (R)-(1-(benzylthio)-3-hydroxypropan-2-yl)carbamate

(R)-tert-Butyl (1-(benzylthio)-3-hydroxypropan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$69.00Login to see priceIn stockIn stock
5g98%$266.00Login to see priceIn stockIn stock
25g98%$754.00Login to see priceIn stockInquiry
100g98%$2949.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (1-(benzylthio)-3-hydroxypropan-2-yl)carbamate
IUPAC Nametert-butyl (R)-(1-(benzylthio)-3-hydroxypropan-2-yl)carbamate
MDL No.MFCD00235923
Molecular FormulaC15H23NO3S
Molecular Weight297.42
SMILESO=C(OC(C)(C)C)N[C@H](CO)CSCC1=CC=CC=C1
InChI KeyMEZQRZMTIJTPIY-CYBMUJFWSA-N
SynonymCarbamic acid, N-[(1R)-1-(hydroxymethyl)-2-[(phenylmethyl)thio]ethyl]-, 1,1-dimethylethyl ester | (R)-tert-butyl 1-(benzylthio)-3-hydroxypropan-2-ylcarbamate | TERT-BUTYL N-[(2R)-1-(BENZYLSULFANYL)-3-HYDROXYPROPAN-2-YL]CARBAMATE | Boc-S-Benzyl-L-cysteinol
CAS No.139428-96-9
PubChem CID11738051

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACBNJI481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBNJI481 route product structure diagram
    ACBNJI481139428-96-9 In Stock
Inquiry

2. ACBNJI481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBNJI481 route product structure diagram
    ACBNJI481139428-96-9 In Stock
Inquiry

Comments (0)